Product Information
INVOKANA 300 MG TABLET is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $19.1197 per EA under NDC 50458014130. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Mar 29, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458014130
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CANAGLIFLOZINApproval Type
New Drug (NDA)
FDA Application
NDA204042FDA Approved
3/29/2013
TE Code
AB
On Market Since
3/29/2013
Pharmacological Classes
Price Statistics
The NADAC for INVOKANA 300 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 124.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.1197 per EA |
|---|---|
| All-time high | $19.1645 (Sep 11, 2024) |
| All-time low | $8.5092 (Nov 28, 2013) |
| 52-week high | $19.1530 |
| 52-week low | $19.1197 |
| Median price | $16.5816 |
| Average price | $15.6858 |
| Largest weekly change | +9.9% (Jan 15, 2014) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of INVOKANA 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for INVOKANA 300 MG TABLET, manufactured by Janssen Pharmaceuticals Inc., is $19.1197 per EA (NDC 50458014130), effective Aug 19, 2026.
How has the price of INVOKANA 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for INVOKANA 300 MG TABLET has risen 124.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for INVOKANA 300 MG TABLET?
Since Nov 28, 2013, the NADAC for INVOKANA 300 MG TABLET has ranged from a low of $8.5092 (Nov 28, 2013) to a high of $19.1645 (Sep 11, 2024), with a median of $16.5816 per EA.
Are there cheaper alternatives to INVOKANA 300 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as INVOKANA 300 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures INVOKANA 300 MG TABLET?
INVOKANA 300 MG TABLET (NDC 50458014130) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.